News

New research into an anti-inflammatory drug for treating lung disease in pre-term babies has shown it also has the potential to prevent the disease’s subsequent complication, pulmonary hypertension (PH), a vascular condition that leads to heart failure and death in 50 per cent of cases.…  Read more

Parkinson’s disease (PD) is a progressive neurodegenerative disorder primarily associated with an inability to initiate and control voluntary movement.…  Read more

Scientists have discovered that the gut-infecting bacterium Clostridium difficile is evolving into two separate species, with one group highly adapted to spread in hospitals.…  Read more

Dr Bilandzic, an ovarian cancer researcher, has been awarded $700,000 for research into deadly ovarian cancer cells called ‘leader cells’, which can survive and even thrive in response to cancer treatment. …  Read more

A world-first clinical trial will see women with fetal growth restriction receive daily doses of melatonin to prevent poor neurological outcomes in babies.…  Read more

For her cutting-edge study that sheds more light on how a baby’s sex is determined, PhD student Brittany Croft has received a top international accolade.…  Read more

A drug used in WW II to treat inflammation may hold the key to saving lives in the fight against flu deaths.…  Read more

Two Hudson Institute researchers, Dr Jun Yang and Dr Maree Bilandzic have been successful in the 2019 IMPACT Philanthropy program, from Perpetual, which are awarded to organisations based on their strategy, outcomes, capability and leaderships.…  Read more

There is a major gap in the rapidly growing cell therapy industry: qualified staff who can undertake the cell manufacturing needed as part of the therapy. …  Read more

Influenza expert Dr Michelle Tate answers frequently asked questions about the flu and addresses misconceptions that often come up in conversation during the winter months.…  Read more